Getachew Mekasha M D Ph D is categorized under Family Practice Doctors in Washington, DC and active since 2012.
Getachew Mekasha M D Ph D was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Getachew Mekasha at the company’s single location by writing to 2139 Georgia Avenue Nw 3a, Washington, District of Columbia DC 20001 or by phoning (202) 865-1881. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Getachew Mekasha M D Ph D |
Contact Person: | Getachew Mekasha |
Address: | 2139 Georgia Avenue Nw 3a, Washington, District of Columbia 20001 |
Phone Number: | (202) 865-1881 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Family Practice Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Getachew Mekasha M D Ph D was started in 2012 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Getachew Mekasha for inquiries that concern Getachew Mekasha M D Ph D by calling the company number (202) 865-1881, as your correspondence is most welcome. Additionally, the physical location of the single location of Getachew Mekasha M D Ph D can be found at the coordinates 38.918882,-77.021733 as well as the street address 2139 Georgia Avenue Nw 3a in Washington, District of Columbia 20001.
For its online presence, you may visit Getachew Mekasha M D Ph D’s website at and engage with its social media outlets through on Twitter and on Facebook.